BIMODALITY AND TRIMODALITY THERAPY IN STAGE III NSCLC: ANALYSIS OF TOXICITY AND PATTERNS OF RECURRENCE

被引：0
|
作者：
Van Reij, Ellen J. F.
Phernambucq, Erik C.
De Haan, Patricia F.
Oei, Swie S.
Smit, Egbert F. [1 ]
Paul, M. A. [2 ]
Senan, Suresh
机构：
[1] Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Thorac Surg, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; trimodality; advanged stage;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1590 / S1590
页数：1
相关论文
共 50 条
  • [1] Outcomes of Bimodality and Trimodality Therapy in Patients with Stage III Non-small Cell Lung Cancer (NSCLC)
    Hope, A. J.
    Coate, L. E.
    Massey, C.
    Sacher, A.
    Barrett, K.
    Keshavjee, S.
    Darling, G.
    Leighl, N. B.
    Bezjak, A.
    Shepherd, F. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S505 - S505
  • [2] Pneumonectomy is not a risk factor in trimodality therapy for stage III NSCLC
    Steger, Volker
    Walles, Thorsten
    Kosan, Bora
    Veit, Stefanie
    Walker, Tobias
    Kyriss, Thomas
    Friedel, Godehard
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S520 - S521
  • [3] Patterns of Recurrence After Trimodality Therapy for Esophageal Cancer
    Dorth, Jennifer A.
    Pura, John A.
    Palta, Manisha
    Willett, Christopher G.
    Uronis, Hope E.
    D'Amico, Thomas A.
    Czito, Brian G.
    [J]. CANCER, 2014, 120 (14) : 2099 - 2105
  • [4] Recurrence patterns following curative therapy for stage I NSCLC.
    Butts, Emily
    Gococo-Benore, Denise
    Pai, Tanmayi
    Chen, Ruqin
    Manochakian, Rami
    Lou, Yanyan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] PFS and recurrence patterns after CCRT with durvalumab for stage III and recurrent NSCLC
    Kishi, N.
    Matsuo, Y.
    Shintani, T.
    Ogura, M.
    Mitsuyoshi, T.
    Araki, N.
    Fujii, K.
    Okumura, S.
    Nakamatsu, K.
    Kishi, T.
    Atsuta, T.
    Sakamoto, T.
    Otsu, S.
    Katagiri, T.
    Narabayashi, M.
    Fujishiro, S.
    Iizuka, Y.
    Ozasa, H.
    Mizowaki, T.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1077 - S1078
  • [6] Outcomes and toxicity in patients treated with bimodality or trimodality therapy for esophageal carcinoma with intensity modulated radiation therapy (IMRT)
    Patel, Ajay
    Ko, Stephen
    James, Sarah Elizabeth
    Ben Ashman, Jonathan
    Rule, William G.
    Hobbs, Corey James
    Hallemeier, Christopher Leigh
    Brennan, Emily R.
    Heckman, Michael
    Tzou, Katherine S.
    Vallow, Laura
    Peterson, Jennifer Layton
    Miller, Robert Clell
    Buskirk, Steven J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [7] Patterns of recurrence in esophageal cancer patients treated with trimodality therapy
    Tahir, Mehmood
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on toxicity and immune therapy
    Cortiula, F.
    Hendriks, L.
    Wijsman, R.
    Debakker, S.
    Steens, M.
    Peeters, S. T.
    Michelotti, A.
    Sijtsema, N. M.
    Urban, S.
    Niezink, A.
    Dursun, S.
    Bootsma, G.
    Canters, R.
    Tohidinezhad, F.
    Fasola, G.
    Rinaldi, I.
    Taasti, V.
    Houben, R.
    De Ruysscher, D.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S984 - S985
  • [9] Early Outcomes and Toxicity in Patients Treated With Bimodality or Trimodality Therapy for Esophageal Carcinoma With Intensity Modulated Radiation Therapy (IMRT)
    Kowalchik, K. V.
    Kim, G.
    Johnson, E.
    Paryani, N.
    Ko, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S310 - S310
  • [10] Early Outcomes and Toxicity in Patients Treated with Bimodality or Trimodality Therapy for Esophageal Carcinoma with Intensity Modulated Radiation Therapy (IMRT)
    Kowalchik, K. V.
    Kim, G.
    Johnson, E.
    Paryani, N.
    Ko, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S302 - S303
12345